Overview

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the feasibility of selecting personalized therapies for colon cancer patients who have failed standard treatments, using a new methodology based on the determination of a profile of chemosensitivity by comprehensive genetic expression analysis from tumor samples.
Phase:
Phase 2
Details
Lead Sponsor:
Centro Nacional de Investigaciones Oncologicas CARLOS III
Collaborators:
Apices Soluciones S.L.
Grupo Hospital de Madrid
Hospital Universitario de Fuenlabrada
Treatments:
Albumin-Bound Paclitaxel
Capecitabine
Cetuximab
Cisplatin
Dasatinib
Docetaxel
Doxorubicin
Erlotinib Hydrochloride
Etoposide
Etoposide phosphate
Fluorouracil
Gemcitabine
Irinotecan
Liposomal doxorubicin
Mitomycin
Mitomycins
Oxaliplatin
Paclitaxel
Pemetrexed
Raltitrexed
Sorafenib
Topotecan
Vinorelbine